Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test

Blinded evaluation study with leading global IVD player demonstrated diagnostic performance in line with FDA requirements for antibiotic susceptibility testing (AST).

- Already received orders for more than 1,000 molecular AST tests offered under the brand name ARESupa – Universal Pathogenome Assay

- Total contractual order volume received in 2019 for next-generation sequencing tests as well as advanced bioinformatics, AI services and certain rights amounts to over EUR 2 million

Read more